rs121908098
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000258415.9(CYP27A1):c.1420C>T(p.Arg474Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R474Q) has been classified as Pathogenic.
Frequency
Consequence
ENST00000258415.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP27A1 | NM_000784.4 | c.1420C>T | p.Arg474Trp | missense_variant | 8/9 | ENST00000258415.9 | NP_000775.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP27A1 | ENST00000258415.9 | c.1420C>T | p.Arg474Trp | missense_variant | 8/9 | 1 | NM_000784.4 | ENSP00000258415 | P1 | |
CYP27A1 | ENST00000494263.5 | n.2132C>T | non_coding_transcript_exon_variant | 6/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250398Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135678
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461856Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727224
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74342
ClinVar
Submissions by phenotype
Cholestanol storage disease Pathogenic:12
Pathogenic, no assertion criteria provided | curation | GeneReviews | Aug 01, 2013 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 17, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Mar 01, 2020 | Review of the variants reported in Reuter et al., 2017, PMID: 28097321: PS3,PM2,PM3_Strong,PP3 - |
Pathogenic, criteria provided, single submitter | clinical testing | Breakthrough Genomics, Breakthrough Genomics | Apr 16, 2021 | This variant was previously reported in compound heterozygous state in an chinese individual affected with peripheral neuropathy [PMID: 33313117]. It was reported as fourth most common variant in cerebrotendinous xanthomatosis Japanese patients and was previously identified in 61-year-old Japanese patient with pure spinal form of cerebrotendinous xanthomatosis, who developed dysesthesia of the lower limbs and gait disturbance at 57 years of age [PMID: 32581172]. The p.Arg474Trp variant was previously classified as ‘deleterious’ based on insilico predictions [PMID: 32344004]. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 474 of the CYP27A1 protein (p.Arg474Trp). This variant is present in population databases (rs121908098, gnomAD 0.02%). This missense change has been observed in individual(s) with cerebrotendinous xanthomatosis (PMID: 7915755, 10406988, 12270007, 17319284, 22336472, 29321515). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as p.Arg441Trp. ClinVar contains an entry for this variant (Variation ID: 4259). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CYP27A1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects CYP27A1 function (PMID: 12270007). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jun 12, 2019 | This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM2,PM3. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 26, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 05, 2023 | - - |
Pathogenic, no assertion criteria provided | research | Department of Rehabilitation Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea | Feb 11, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics | Oct 11, 2024 | A heterozygous missense variation in exon 8 of the CYP27A1 gene that results in the amino acid substitution of tryptophan for Arginine at codon 474 was detected. The observed variant c.1420C>T (p.Arg474Trp) has a minor allele frequency of 0.0012% and 0.0017% gnomAD and ExAC databases. The in silico prediction of the variant is damaging by Revel, MutationTaster2, MetaLR, BayesDel and DANN. In summary, the variant meets our criteria to be classified as a variant of pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 1994 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Jun 22, 2017 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 22, 2023 | Published functional studies demonstrate a damaging effect on enzyme activity (Gupta RP et al., 2007; Kim KS et al., 1994); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 8614539, 34426522, 33414089, 7915755, 32868181, 33494148, 17697869, 33763395, 32581172, 35614401, 28937538) - |
CYP27A1-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 12, 2024 | The CYP27A1 c.1420C>T variant is predicted to result in the amino acid substitution p.Arg474Trp. This variant, sometimes described as R441W using legacy nomenclature, has been reported in homozygous and compound heterozygous individuals with cerebrotendinous xanthomatosis (Kim et al. 1994. PubMed ID: 7915755; Rystedt et al. 2002. PubMed ID: 12270007; Wang et al. 2007. PubMed ID: 17319284; Gong et al. 2017. PubMed ID: 28937538). Experimental studies in vitro indicate that the p.Arg474Trp variant has less than 5% of the enzyme activity compared to wild-type enzyme (Rystedt et al. 2002. PubMed ID: 12270007). An alternate missense change at the same amino acid position, p.Arg474Gln, has also been reported in patients with cerebrotendinous xanthomatosis (Kim et al. 1994. PubMed ID: 7915755; Gong et al. 2017. PubMed ID: 28937538). The c.1420C>T (p.Arg474Trp) variant is reported in 0.016% of alleles in individuals of East Asian descent in gnomAD. Based on the available evidence, we classify this variant as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at